Top in GI: Low-FODMAP diet, CRC screening bill

A low-FODMAP diet tailored for short- or long-term use improved symptoms of irritable bowel syndrome-diarrhea, according to a recent study. It was the top story in gastroenterology last week.

Another top story was about new legislation that protects Medicare patients from unexpected costs if polyps are found and removed during colonoscopies.

Read these and more top stories in gastroenterology below:

Low-FODMAP diet leads to improvements in IBS-D symptoms

A strict, short-term, low-FODMAP diet and a “modified,” long-term, low-FODMAP diet were linked to improvements in symptoms and quality of life in irritable bowel syndrome-diarrhea predominant patients, according to study results. Read more.

Q&A: CRC screening bill removes unexpected costs for polyp detection, removal

The organization Fight Colorectal Cancer is celebrating that the Removing Barriers to Colorectal Cancer Screening Act has been recently signed into law. Read more.

Duodenal mucosal resurfacing plus liraglutide eliminates need for insulin in type 2 diabetes

Adding liraglutide and lifestyle counseling to duodenal mucosal resurfacing eliminated the need for insulin therapy in most patients with type 2 diabetes through 18 months, according to data from a feasibility study. Read more.

Delayed colonoscopy linked with higher risk for CRC

Delayed colonoscopy after an abnormal stool-based screening test was associated with increased risk for colorectal cancer, according to study results. Read more.

FMT converts cancer immunotherapy non-responders to responders

Adding fecal microbiota transplantation to treatment in patients with programmed cell death protein 1 melanoma altered the gut microbiome and reprogrammed tumor microenvironment to overcome resistance to anti-programmed cell death protein 1 therapy, according to study results. Read more.